Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Thoracic Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 353 articles:
HTML format
Text format



Single Articles


    April 2017
  1. MALLIDI JR, Robinson P, Visintainer PF, Lotfi AS, et al
    Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.27042.
    PubMed     Text format     Abstract available


  2. SCHREIBER T, Wah Htun W, Blank N, Telila T, et al
    Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Catheter Cardiovasc Interv. 2017 Apr 18. doi: 10.1002/ccd.26979.
    PubMed     Text format     Abstract available


  3. SANDOVAL Y, Brilakis ES
    The role of rotational atherectomy in contemporary chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017;89:829-831.
    PubMed     Text format     Abstract available


    March 2017
  4. DIN JN, Snow TM, Rao SV, Klinke WP, et al
    Variation in practice and concordance with guideline criteria for length of stay after elective percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 31. doi: 10.1002/ccd.26992.
    PubMed     Text format     Abstract available


  5. MINA GS, Firouzbakht T, Modi K, Dominic P, et al
    Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2017 Mar 24. doi: 10.1002/ccd.26985.
    PubMed     Text format     Abstract available


  6. VISHNEVSKY A, Julien HM, Fischman DL, Walinsky P, et al
    Unrecognized coronary vasospasm in patients referred for percutaneous coronary intervention: Intracoronary nitroglycerin, the forgotten stepchild of cardiovascular guidelines.
    Catheter Cardiovasc Interv. 2017 Mar 20. doi: 10.1002/ccd.27034.
    PubMed     Text format     Abstract available


  7. AZZALINI L, Carlino M, Brilakis ES, Vo M, et al
    Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture".
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27025.
    PubMed     Text format     Abstract available


  8. SOLA M, Venkatesh K, Caughey M, Rayson R, et al
    Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26963.
    PubMed     Text format     Abstract available


  9. KARIMI GALOUGAHI K, Mintz GS, Karmpaliotis D, Ali ZA, et al
    Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26999.
    PubMed     Text format     Abstract available


  10. SUKUL D, Seth M, Schreiber T, Khandelwal A, et al
    The comparative safety and effectiveness of bivalirudin versus heparin monotherapy in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan cardiovascular consortium.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.27001.
    PubMed     Text format     Abstract available


  11. MAHMOUD AN, Elgendy IY, Mentias A, Saad M, et al
    Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26970.
    PubMed     Text format     Abstract available


  12. WILSON WM, Walsh SJ, Bagnall A, Yan AT, et al
    One-year outcomes after successful chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26980.
    PubMed     Text format     Abstract available


  13. MENTIAS A, Mahmoud AN, Elgendy IY, Elgendy AY, et al
    Ischemic postconditioning during primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26965.
    PubMed     Text format     Abstract available


  14. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    Role of residual acute stent malapposition in percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26974.
    PubMed     Text format     Abstract available


  15. GUERRERO M, Wang DD, Himbert D, Urena M, et al
    Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26975.
    PubMed     Text format     Abstract available


  16. SHARMA D, Kotowycz MA, Sharma V, Choudhury A, et al
    Characteristics and outcomes of patients undergoing percutaneous coronary intervention within 1 year of coronary artery bypass graft surgery.
    Catheter Cardiovasc Interv. 2017 Mar 7. doi: 10.1002/ccd.26853.
    PubMed     Text format     Abstract available


  17. QI J, Li Y, Li J, Jing Q, et al
    Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  18. HE C, Ma YL, Wang CS, Song Y, et al
    Effect of coronary dominance on 2-year outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  19. PALMERINI T
    Myocardial revascularization with percutaneous coronary intervention: To complete or not to complete?
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format    


  20. CHE W, Dong H, Jiang X, Peng M, et al
    Subclavian artery stenting for coronary-subclavian steal syndrome.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  21. LIAO YB, Zhao ZG, Wei X, Xu YN, et al
    Transcatheter aortic valve implantation with the self-expandable venus A-Valve and CoreValve devices: Preliminary Experiences in China.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  22. QIU M, Li Y, Li J, Xu K, et al
    Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.
    Catheter Cardiovasc Interv. 2017;89.
    PubMed     Text format     Abstract available


  23. BELARDI JA, Albertal M
    Non-cardiac surgery after PCI: Watch out for complex lesions.
    Catheter Cardiovasc Interv. 2017;89:627-628.
    PubMed     Text format    


  24. AZZALINI L, Brilakis ES
    Ipsilateral vs. contralateral vs. no collateral (antegrade only) chronic total occlusion percutaneous coronary interventions: What is the right choice for your practice?
    Catheter Cardiovasc Interv. 2017;89:656-657.
    PubMed     Text format    


    February 2017
  25. ZAHR F, Cigarroa JE
    Revascularization after coronary artery bypass grafting; Another episode in a long saga.
    Catheter Cardiovasc Interv. 2017;89:349-350.
    PubMed     Text format    


  26. COOLS B, Rega F, Gewillig M
    Transhepatic implant of a trimmed Melody valved stent in tricuspid position in a 1-year-old infant.
    Catheter Cardiovasc Interv. 2017;89:E84-E89.
    PubMed     Text format     Abstract available


  27. BUTERA G, Piazza L, Heles M
    PFO "angioplasty": The preparation of a very stiff and long tunnel for device closure.
    Catheter Cardiovasc Interv. 2017;89:480-483.
    PubMed     Text format     Abstract available


  28. JAMES RODRIGUEZ R, Prasad A
    Transcatheter aortic valve replacement and renal function: A complex relationship.
    Catheter Cardiovasc Interv. 2017;89:460-461.
    PubMed     Text format    


  29. PELBERG J, Gray WA
    Good to great: TAVR tackles stroke risk.
    Catheter Cardiovasc Interv. 2017;89:478-479.
    PubMed     Text format    


  30. CONDADO JF, Block PC
    Gender inequalities in transcatheter aortic valve replacement: The jury is still out.
    Catheter Cardiovasc Interv. 2017;89:436-437.
    PubMed     Text format    


  31. YADAV PK, Gilchrist IC
    Significant leak after TAVR: A plug is an option.
    Catheter Cardiovasc Interv. 2017;89:468-469.
    PubMed     Text format    


  32. ZHANG D, Li Y, Yin D, He Y, et al
    Risk stratification of periprocedural myocardial infarction after percutaneous coronary intervention: Analysis based on the SCAI definition.
    Catheter Cardiovasc Interv. 2017 Feb 13. doi: 10.1002/ccd.26939.
    PubMed     Text format     Abstract available


  33. RAVAT H, Garekar S, Changela V
    Left main coronary angioplasty of a 9-year-old child with bioresorable vascular scaffold.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26896.
    PubMed     Text format     Abstract available


  34. DEHARO P, Strange JW, Mozid A
    Primary percutaneous coronary intervention of native chronic total occlusions to treat ST elevation myocardial infarction secondary to acute vein graft occlusion.
    Catheter Cardiovasc Interv. 2017 Feb 10. doi: 10.1002/ccd.26905.
    PubMed     Text format     Abstract available


  35. CZARNY MJ, Hwang CW, Naiman DQ, Lemmon CC, et al
    Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.
    Catheter Cardiovasc Interv. 2017 Feb 4. doi: 10.1002/ccd.26953.
    PubMed     Text format     Abstract available


  36. PARSH J, Seth M, Green J, Sutton NR, et al
    Coronary artery perforations after contemporary percutaneous coronary interventions: Evaluation of incidence, risk factors, outcomes, and predictors of mortality.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26917.
    PubMed     Text format     Abstract available


  37. VISVESWARAN GK, Cohen M, Seliem A, DiVita M, et al
    A single center tertiary care experience utilizing the large volume mega 50cc intra-aortic balloon counterpulsation in contemporary clinical practice.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26908.
    PubMed     Text format     Abstract available


  38. COHOON KP, Mack MJ, Holmes DR
    Public reporting: A new threat to high-risk patients and medical innovation.
    Catheter Cardiovasc Interv. 2017;89:335-337.
    PubMed     Text format    


  39. BOLER AN, Hilliard AA, Gordon BM
    Functional assessment of anomalous right coronary artery using fractional flow reserve: An Innovative Modality to Guide Patient Management.
    Catheter Cardiovasc Interv. 2017;89:316-320.
    PubMed     Text format     Abstract available


  40. POTERUCHA JT, Taggart NW, Johnson JN, Cannon BC, et al
    Intravascular and hybrid intraoperative stent placement for baffle obstruction in transposition of the great arteries after atrial switch.
    Catheter Cardiovasc Interv. 2017;89:306-314.
    PubMed     Text format     Abstract available


  41. LIGON RA, Petit CJ
    Not that atretic: Use of an atretic femoral vein for transcatheter pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2017;89:321-323.
    PubMed     Text format     Abstract available


  42. SHAH AH, Horlick EM, Eicken A, Asnes JD, et al
    Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Bjork-fontan procedure.
    Catheter Cardiovasc Interv. 2017;89:298-305.
    PubMed     Text format     Abstract available


  43. PAREKH D, Krajcer Z
    Atrial baffle stenting: A complex solution to an aging problem.
    Catheter Cardiovasc Interv. 2017;89:314-315.
    PubMed     Text format    


  44. HAGLER DJ
    The Lababidi Procedure: Is Neonatal Balloon Aortic Valvotomy Worth the Risk?
    Catheter Cardiovasc Interv. 2017;89:296-297.
    PubMed     Text format    


    January 2017
  45. NAGANUMA T, Colombo A, Lesiak M, Capodanno D, et al
    Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
    Catheter Cardiovasc Interv. 2017;89:47-56.
    PubMed     Text format     Abstract available


  46. BELARDI JA, Albertal M
    Double-stenting in distal left main lesions: Let's crush.
    Catheter Cardiovasc Interv. 2017;89:24-25.
    PubMed     Text format     Abstract available


  47. MCCABE JM, Dean LS
    Pass the Rock: calcium, the achilles heel of transcatheter valve replacement.
    Catheter Cardiovasc Interv. 2017;89:142-143.
    PubMed     Text format     Abstract available


  48. CHATTERJEE A, Hillegass WB
    Unprotected Left Main Disease and Percutaneous Intervention: A Prototype for Precision Medicine.
    Catheter Cardiovasc Interv. 2017;89:11-12.
    PubMed     Text format     Abstract available


    December 2016
  49. NOMAN A, Balasubramaniam K, Alhous MH, Lee K, et al
    Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26882.
    PubMed     Text format     Abstract available



  50. Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by transradialaccess site and systemic implementation of AngioX) sub-study.
    Catheter Cardiovasc Interv. 2016;88:1188.
    PubMed     Text format    


  51. NGUYEN-TRONG PJ, Martinez Parachini JR, Resendes E, Karatasakis A, et al
    Procedural outcomes with use of the flash ostial system in aorto-coronary ostial lesions.
    Catheter Cardiovasc Interv. 2016;88:1067-1074.
    PubMed     Text format     Abstract available


  52. KRAJCER Z, Parekh D
    Dynamic Sheaths, in the Nick of Time or Past Their Prime?
    Catheter Cardiovasc Interv. 2016;88:1153-1154.
    PubMed     Text format     Abstract available


  53. BROWN BJ, Abbott JD
    A helping hand: GuideLiner use to facilitate stent delivery.
    Catheter Cardiovasc Interv. 2016;88:1065-1066.
    PubMed     Text format     Abstract available


    November 2016
  54. MASSUMI M, Krajcer Z
    To BAV or not to BAV, that is a TAVR question.
    Catheter Cardiovasc Interv. 2016;88:986-987.
    PubMed     Text format    


  55. DANEK BA, Brilakis ES
    Serenity, courage, and wisdom: The keys to successful coronary calcification treatment.
    Catheter Cardiovasc Interv. 2016;88:897-898.
    PubMed     Text format    


  56. SAFIAN RD
    Provisional rotablator for calcified lesions: The Russian roulette of PCI.
    Catheter Cardiovasc Interv. 2016;88:889-890.
    PubMed     Text format    


  57. FAURIE B, Abdellaoui M, Wautot F, Staat P, et al
    Rapid pacing using the left ventricular guidewire: Reviving an old technique to simplify BAV and TAVI procedures.
    Catheter Cardiovasc Interv. 2016;88:988-993.
    PubMed     Text format     Abstract available


  58. RUPARELIA N, Mangieri A, Ancona M, Giannini F, et al
    Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure.
    Catheter Cardiovasc Interv. 2016;88:994-1001.
    PubMed     Text format     Abstract available


  59. IANNACCONE M, Barbero U, D'ascenzo F, Latib A, et al
    Rotational atherectomy in very long lesions: Results for the ROTATE registry.
    Catheter Cardiovasc Interv. 2016;88:E164-E172.
    PubMed     Text format     Abstract available


  60. PRASAD M, Geske JB, Sorajja P, Ommen SR, et al
    Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction.
    Catheter Cardiovasc Interv. 2016;88:962-970.
    PubMed     Text format     Abstract available


  61. KAWAMOTO H, Latib A, Ruparelia N, Boccuzzi GG, et al
    Planned versus provisional rotational atherectomy for severe calcified coronary lesions: Insights From the ROTATE multi-center registry.
    Catheter Cardiovasc Interv. 2016;88:881-889.
    PubMed     Text format     Abstract available


  62. SHAH R, Matin K, Rogers KC, Rao SV, et al
    Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26859.
    PubMed     Text format     Abstract available


  63. ASHER E, Mansour J, Wheeler A, Kendrick D, et al
    Cost awareness decreases total percutaneous coronary intervention procedural cost: The SHOPPING (Show How Options in Price for Procedures Can Be Influenced Greatly) trial.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26835.
    PubMed     Text format     Abstract available


  64. CHENG R, Vanichsarn C, Patel JK, Currier J, et al
    Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26830.
    PubMed     Text format     Abstract available


  65. KOIFMAN E, Gaglia MA Jr, Escarcega RO, Bernardo NL, et al
    Comparison of transradial and transfemoral access in patients undergoing percutaneous coronary intervention for complex coronary lesions.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26669.
    PubMed     Text format     Abstract available


  66. WIMMER NJ, Dufour AB, Cho K, Gagnon DR, et al
    Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26831.
    PubMed     Text format     Abstract available


  67. MCELHINNEY DB
    Hybrid transcatheter pulmonary valve replacement: Moving into the mainstream?
    Catheter Cardiovasc Interv. 2016;88:811-813.
    PubMed     Text format    


  68. SARRAF M, Hillegass W
    Routine invasive evaluation in non ST elevation myocardial infarction (NSTEMI-ACS): Optimizing best.
    Catheter Cardiovasc Interv. 2016;88:775-776.
    PubMed     Text format    


  69. SOSNOWSKI C, Matella T, Fogg L, Ilbawi M, et al
    Hybrid pulmonary artery plication followed by transcatheter pulmonary valve replacement: Comparison with surgical PVR.
    Catheter Cardiovasc Interv. 2016;88:804-810.
    PubMed     Text format     Abstract available


  70. ELGENDY IY, Kumbhani DJ, Mahmoud AN, Wen X, et al
    Routine invasive versus selective invasive strategies for Non-ST-elevation acute coronary syndromes: An Updated meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016;88:765-774.
    PubMed     Text format     Abstract available


  71. LINDSAY I, Aboulhosn J, Salem M, Levi D, et al
    Aortic root compression during transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2016;88:814-821.
    PubMed     Text format     Abstract available


    October 2016
  72. KISCHE S, D'Ancona G, Agma HU, El-Achkar G, et al
    Trans-catheter aortic valve implantation with the direct flow medical prosthesis: Single center short-term clinical and echocardiographic outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26528.
    PubMed     Text format     Abstract available


  73. D'ANCONA G, Agma HU, Ince H, El-Achkar G, et al
    Transcatheter aortic valve implantation with the direct flow medical prosthesis: Impact of native aortic valve calcification degree on outcomes.
    Catheter Cardiovasc Interv. 2016 Oct 14. doi: 10.1002/ccd.26517.
    PubMed     Text format     Abstract available


  74. YETGIN T, van Kranenburg M, Ten Cate T, Duncker DJ, et al
    Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial.
    Catheter Cardiovasc Interv. 2016;88:508-514.
    PubMed     Text format     Abstract available


  75. SCHNEIDER AE, Delaney JW, Cabalka AK
    Non-infectious thrombosis of the melody(R) valve: A tale of two cities.
    Catheter Cardiovasc Interv. 2016;88:600-604.
    PubMed     Text format     Abstract available


  76. EFTYCHIOU C, Barmby DS, Wilson SJ, Ubaid S, et al
    Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience.
    Catheter Cardiovasc Interv. 2016;88:546-553.
    PubMed     Text format     Abstract available


  77. ABRAHAM BP, Gilliam E, Kim DW, Wolf MJ, et al
    Early catheterization after initiation of extracorporeal membrane oxygenation support in children is associated with improved survival.
    Catheter Cardiovasc Interv. 2016;88:592-599.
    PubMed     Text format     Abstract available


  78. ANGULO-LLANOS R, Sarnago-Cebada F, Rivera AR, Elizaga Corrales J, et al
    Two-Year Follow Up After Surgical Versus Percutaneous Paravalvular Leak Closure: A Non-Randomized Analysis.
    Catheter Cardiovasc Interv. 2016;88:626-634.
    PubMed     Text format     Abstract available


  79. YILDIRIM A, Goktekin O, Gorgulu S, Norgaz T, et al
    A New Specific Device in Transcatheter Prosthetic Paravalvular Leak Closure: A Prospective Two-Center Trial.
    Catheter Cardiovasc Interv. 2016;88:618-624.
    PubMed     Text format     Abstract available


  80. TEBALDI M, Biscaglia S, Fineschi M, Manari A, et al
    Fractional Flow Reserve Evaluation and Chronic Kidney Disease: Analysis From a Multicenter Italian Registry (the FREAK Study).
    Catheter Cardiovasc Interv. 2016;88:555-562.
    PubMed     Text format     Abstract available


  81. BASAVARAJAIAH S, Naganuma T, Latib A, Sticchi A, et al
    Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Catheter Cardiovasc Interv. 2016;88:522-528.
    PubMed     Text format     Abstract available


  82. SAFIAN RD
    The Third Rail of Interventional Cardiology: Revascularization of Non-Infarct-Related Arteries During Primary PCI.
    Catheter Cardiovasc Interv. 2016;88:506-507.
    PubMed     Text format    


  83. PAIXAO A, Cilingiroglu M
    Paravalvular Leaks: One Size (or Shape) Doesn't Always Fit All?
    Catheter Cardiovasc Interv. 2016;88:624-625.
    PubMed     Text format     Abstract available


  84. DAVIDSON LJ, Davidson CJ
    Stroke Prevention: Let's Prepare for Generation X TAVR.
    Catheter Cardiovasc Interv. 2016;88:653-655.
    PubMed     Text format     Abstract available


  85. FELDMAN T, Nietlispach F
    Surgical vs. Percutaneous Approaches to Paravalvular Leak: Is Closure Too Little Too Late, or Just Not Soon Enough.
    Catheter Cardiovasc Interv. 2016;88:634-635.
    PubMed     Text format    


    September 2016
  86. WANG H, Li Y, Cong H, Ding S, et al
    Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
    Catheter Cardiovasc Interv. 2016 Sep 28. doi: 10.1002/ccd.26804.
    PubMed     Text format     Abstract available


  87. VERMA S, Burkhoff D, O'Neill WW
    Avoiding hemodynamic collapse during high-risk percutaneous coronary intervention: Advanced hemodynamics of impella support.
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26795.
    PubMed     Text format     Abstract available


  88. SUKUL D, Seth M, Dixon SR, Zainea M, et al
    Clinical outcomes of percutaneous coronary intervention in patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26781.
    PubMed     Text format     Abstract available


  89. CHANDRASEKHAR J, Bansilal S, Baber U, Sartori S, et al
    Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26716.
    PubMed     Text format     Abstract available


  90. SULLIVAN PM, Rubio AE, Johnston TA, Jones TK, et al
    Long-term outcomes and re-interventions following balloon aortic valvuloplasty in pediatric patients with congenital aortic stenosis: A single-center study.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26722.
    PubMed     Text format     Abstract available


  91. DILETTI R, Tchetche D, Barbato E, Latib A, et al
    Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.
    Catheter Cardiovasc Interv. 2016;88:397-406.
    PubMed     Text format     Abstract available


  92. GENEREUX P, Bettinger N, Redfors B, Lee AC, et al
    Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Catheter Cardiovasc Interv. 2016;88:369-77.
    PubMed     Text format     Abstract available


  93. BROWN SC, Cools B, Gewillig M
    Cracking a tricuspid perimount bioprosthesis to optimize a second transcatheter sapien valve-in-valve placement.
    Catheter Cardiovasc Interv. 2016;88:456-9.
    PubMed     Text format     Abstract available


  94. KORNOWSKI R
    The 3 S's of the Sapien balloon expandable valve.
    Catheter Cardiovasc Interv. 2016;88:476-8.
    PubMed     Text format     Abstract available


  95. SOTOMI Y, Serruys PW
    Promising, but still a matter of debate.
    Catheter Cardiovasc Interv. 2016;88:378-9.
    PubMed     Text format     Abstract available


  96. BELARDI JA, Albertal M
    To achieve, or not to achieve complete revascularization.
    Catheter Cardiovasc Interv. 2016;88:338-9.
    PubMed     Text format     Abstract available


    August 2016
  97. KORABATHINA R, Levine JC, Coppola JT
    Innovative use of a guideliner catheter to assist in snare retrieval of an entrapped kinked guide catheter during transradial coronary intervention.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26774.
    PubMed     Text format     Abstract available


  98. AMINIAN A, Iglesias JF, Van Mieghem C, Zuffi A, et al
    First prospective multicenter experience with the 7 French Glidesheath slender for complex transradial coronary interventions.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26773.
    PubMed     Text format     Abstract available


  99. MOTTILLO S, Filion KB, Joseph L, Eisenberg MJ, et al
    Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta-regression.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26652.
    PubMed     Text format     Abstract available


  100. FERKO N, Ferrante G, Hasegawa JT, Schikorr T, et al
    Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2016 Aug 16. doi: 10.1002/ccd.26700.
    PubMed     Text format     Abstract available


  101. PATEL AD, Ibrahim M, Swaminathan RV, Minhas IU, et al
    Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Aug 13. doi: 10.1002/ccd.26664.
    PubMed     Text format     Abstract available


  102. MINGES KE, Herrin J, Fiorilli PN, Curtis JP, et al
    Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26701.
    PubMed     Text format     Abstract available


  103. MENEGUZ-MORENO RA, Ramos AI, Siqueira D, de Castro-Filho A, et al
    Prognostic value of renal function in patients with aortic stenosis treated with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26693.
    PubMed     Text format     Abstract available


  104. BRADLEY EA, Berman D, Daniels CJ
    First implantable hemodynamic monitoring device placement in single ventricle fontan anatomy.
    Catheter Cardiovasc Interv. 2016;88:248-52.
    PubMed     Text format     Abstract available


  105. NOONAN P, Kudumula V, Anderson B, Ramchandani B, et al
    Stenting of the left pulmonary artery after palliation of hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2016;88:225-32.
    PubMed     Text format     Abstract available


  106. JIVANJI SG, Derrick G, Khambadkone S
    Doubly committed subarterial ventricular septal defect: A risk factor for aortic distortion in patients considered for percutaneous pulmonary valve implantation?
    Catheter Cardiovasc Interv. 2016;88:244-7.
    PubMed     Text format     Abstract available


  107. SPITZER SG, Wilbring M, Alexiou K, Stumpf J, et al
    Surgical cut-down or percutaneous access-which is best for less vascular access complications in transfemoral TAVI?
    Catheter Cardiovasc Interv. 2016;88:E52-8.
    PubMed     Text format     Abstract available


    July 2016
  108. KATZ M, Carlos Bacelar Nunes Filho A, Caixeta A, Antonio Carvalho L, et al
    Gender-related differences on short- and long-term outcomes of patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2016 Jul 29. doi: 10.1002/ccd.26658.
    PubMed     Text format     Abstract available


  109. ROSSINI R, Angiolillo DJ, Musumeci G, Capodanno D, et al
    Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26629.
    PubMed     Text format     Abstract available


  110. GUERRERO M, Wang DD, O'Neill W
    Percutaneous alcohol septal ablation to acutely reduce left ventricular outflow tract obstruction induced by transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26649.
    PubMed     Text format     Abstract available


  111. MASHAYEKHI K, Behnes M, Valuckiene Z, Bryniarski L, et al
    Comparison of the ipsi-lateral versus contra-lateral retrograde approach of percutaneous coronary interventions in chronic total occlusions.
    Catheter Cardiovasc Interv. 2016 Jul 5. doi: 10.1002/ccd.26611.
    PubMed     Text format     Abstract available


  112. SAFIAN RD
    Saphenous vein bypass graft intervention and embolic protection devices: Time for reassessment (and revision of percutaneous coronary intervention guidelines).
    Catheter Cardiovasc Interv. 2016;88:84-5.
    PubMed     Text format     Abstract available


  113. DANEK BA, Brilakis ES
    How to prevent and treat complications of the retrograde approach to chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016;88:15-7.
    PubMed     Text format     Abstract available


  114. BROWN SC, Proesmans M, Gewillig M
    Reversing left bronchus obstruction by compression of a pulmonary artery stent.
    Catheter Cardiovasc Interv. 2016;88:103-6.
    PubMed     Text format     Abstract available


    June 2016
  115. ARMSTRONG EJ, Graham L, Waldo SW, Valle JA, et al
    Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.
    Catheter Cardiovasc Interv. 2016 Jun 17. doi: 10.1002/ccd.26624.
    PubMed     Text format     Abstract available


  116. COCKBURN J, Dooley M, Parker J, Hill A, et al
    Transcatheter aortic valve-in-valve treatment of degenerative stentless supra-annular Freedom Solo valves: A single centre experience.
    Catheter Cardiovasc Interv. 2016 Jun 17. doi: 10.1002/ccd.26623.
    PubMed     Text format     Abstract available


  117. WERNER N, Zeymer U, Schneider S, Bauer T, et al
    Incidence and clinical impact of stroke complicating transcatheter aortic valve implantation: Results from the German TAVI registry.
    Catheter Cardiovasc Interv. 2016 Jun 3. doi: 10.1002/ccd.26612.
    PubMed     Text format     Abstract available


  118. SETO AH, Jordan Safirstein, Anwaruddin S, Dehghani P, et al
    Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
    Catheter Cardiovasc Interv. 2016;87:1224-30.
    PubMed     Text format     Abstract available


    May 2016
  119. FAZA NN, Mentias A, Parashar A, Chaudhury P, et al
    Bleeding Complications of Triple Antithrombotic Therapy after Percutaneous Coronary Interventions.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26574.
    PubMed     Text format     Abstract available


  120. JOSHI FR, Biasco L, Pedersen F, Holmvang L, et al
    Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26598.
    PubMed     Text format     Abstract available


  121. MURAI T, Kanaji Y, Yonetsu T, Lee T, et al
    Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 May 24. doi: 10.1002/ccd.26596.
    PubMed     Text format     Abstract available


  122. MAHMUD E, Dominguez A, Bahadorani J
    First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.
    Catheter Cardiovasc Interv. 2016 May 18. doi: 10.1002/ccd.26550.
    PubMed     Text format     Abstract available


  123. BANDALI A, Parry-Williams G, Kassam A, Palmer S, et al
    Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
    Catheter Cardiovasc Interv. 2016 May 18. doi: 10.1002/ccd.26564.
    PubMed     Text format     Abstract available


  124. KARATASAKIS A, Tarar MN, Karmpaliotis D, Alaswad K, et al
    Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry.
    Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26568.
    PubMed     Text format     Abstract available


  125. BOCKSCH W, Grossmann B, Geisler T, Steeg M, et al
    Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 May 17. doi: 10.1002/ccd.26562.
    PubMed     Text format     Abstract available


  126. CHANDRASEKHAR J, Baber U, Sartori S, Faggioni M, et al
    Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS Study.
    Catheter Cardiovasc Interv. 2016 May 6. doi: 10.1002/ccd.26606.
    PubMed     Text format     Abstract available


  127. IPEK G, Gungor B, Karatas MB, Onuk T, et al
    Risk factors and outcomes in patients with ectatic infarct-related artery who underwent primary percutaneous coronary intervention after ST elevated myocardial infarction.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26553.
    PubMed     Text format     Abstract available


  128. GONSKA B, Seeger J, Rodewald C, Scharnbeck D, et al
    Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26565.
    PubMed     Text format     Abstract available


  129. LEVI DS, Sinha S, Salem MM, Aboulhosn JA, et al
    Transcatheter native pulmonary valve and tricuspid valve replacement with the sapien XT: Initial experience and development of a new delivery platform.
    Catheter Cardiovasc Interv. 2016 May 3. doi: 10.1002/ccd.26398.
    PubMed     Text format     Abstract available


  130. CHEN J, Nawaz N, Fox Z, Komlo C, et al
    Echocardiographic determinants of LV functional improvement after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016;87:1164-72.
    PubMed     Text format     Abstract available


  131. BLANKENSHIP JC
    Passion: A day in the life of an interventionalist.
    Catheter Cardiovasc Interv. 2016;87:999-1000.
    PubMed     Text format    


  132. DE WOLF D, Dessy H, Haas N
    Use of a new low profile Occlutech PLD device for closure of Fontan fenestrations.
    Catheter Cardiovasc Interv. 2016;87:E243-7.
    PubMed     Text format     Abstract available


  133. PIHKALA JI, Jarvela M, Boldt T, Jokinen E, et al
    Fate of fenestration in children treated with fontan operation.
    Catheter Cardiovasc Interv. 2016;87:E233-9.
    PubMed     Text format     Abstract available


  134. BUTERA G, Taha F
    Two problems and a single solution: Covered stent implantation to close an anterograde pulmonary flow and treat hypoplastic left pulmonary artery after Fontan operation.
    Catheter Cardiovasc Interv. 2016;87:E240-2.
    PubMed     Text format     Abstract available


    April 2016
  135. CARLINO M, Azzalini L, Colombo A
    A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26556.
    PubMed     Text format     Abstract available


  136. O'NEILL BP, Wheatley G, Bashir R, Edmundowicz D, et al
    Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial.
    Catheter Cardiovasc Interv. 2016 Apr 28. doi: 10.1002/ccd.26530.
    PubMed     Text format     Abstract available


  137. ZAMAN S, Gooley R, Cheng V, McCormick L, et al
    Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Apr 23. doi: 10.1002/ccd.26371.
    PubMed     Text format     Abstract available


  138. TURNER ME, Addonizio LJ, Richmond ME, Zuckerman WA, et al
    Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Catheter Cardiovasc Interv. 2016 Apr 16. doi: 10.1002/ccd.26544.
    PubMed     Text format     Abstract available


  139. SHARMA PK, Chhatriwalla AK, Cohen DJ, Jang JS, et al
    Predicting long-term bleeding after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Apr 1. doi: 10.1002/ccd.26529.
    PubMed     Text format     Abstract available


  140. ZWAAN EM, IJsselmuiden AJ, van Rosmalen J, van Geuns RM, et al
    Rationale and design of the ARCUS: Effects of trAnsRadial perCUtaneouS coronary intervention on upper extremity function.
    Catheter Cardiovasc Interv. 2016 Apr 1. doi: 10.1002/ccd.26525.
    PubMed     Text format     Abstract available


  141. HIRA RS, Dean LS
    STAR in CTO PCI: When is STAR not a star?
    Catheter Cardiovasc Interv. 2016;87:893-4.
    PubMed     Text format     Abstract available


  142. VALLURUPALLI S, Uretsky BF
    Deploying bioresorbable vascular scaffolds--tardus, altius, amplius!!
    Catheter Cardiovasc Interv. 2016;87:847-8.
    PubMed     Text format     Abstract available


  143. OESTREICH BA, Sommer P, Armstrong EJ
    Coronary artery embolism from infectious endocarditis treated with catheter thrombectomy using a GuideLiner catheter.
    Catheter Cardiovasc Interv. 2016;87:E197-201.
    PubMed     Text format     Abstract available


  144. INOHARA T, Hayashida K, Watanabe Y, Yamamoto M, et al
    Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries.
    Catheter Cardiovasc Interv. 2016;87:963-70.
    PubMed     Text format     Abstract available


  145. FABRIS E, Caiazzo G, Kilic ID, Serdoz R, et al
    Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres.
    Catheter Cardiovasc Interv. 2016;87:839-46.
    PubMed     Text format     Abstract available


  146. TANAKA A, Ruparelia N, Kawamoto H, Sticchi A, et al
    Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure.
    Catheter Cardiovasc Interv. 2016;87:832-6.
    PubMed     Text format     Abstract available


  147. FUJITA B, Scholtz S, Ensminger S
    Valve-in-valve using an Edwards Sapien XT into a JenaValve in a patient with a low originating left coronary artery and a heavily calcified aorta.
    Catheter Cardiovasc Interv. 2016;87:989-92.
    PubMed     Text format     Abstract available


  148. SUAREZ DE LEZO J, Martin P, Mazuelos F, Novoa J, et al
    Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results.
    Catheter Cardiovasc Interv. 2016;87:E173-82.
    PubMed     Text format     Abstract available


  149. TOROK RD, Fleming GA, Hill KD
    Transcatheter pulmonary embolectomy after fontan.
    Catheter Cardiovasc Interv. 2016;87:939-44.
    PubMed     Text format     Abstract available


    March 2016
  150. SOLHPOUR A, Chang KW, Arain SA, Balan P, et al
    Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myo
    Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26523.
    PubMed     Text format     Abstract available


  151. ADUSUMALLI S, Morris M, Pershad A
    Pseudo-Pericardial Tamponade From Right Ventricular Hematoma After Chronic Total Occlusion Percutaneous Coronary Intervention of the Right Coronary Artery: Successfully Managed Percutaneously With Computerized Tomographic Guided Drainage.
    Catheter Cardiovasc Interv. 2016 Mar 29. doi: 10.1002/ccd.26510.
    PubMed     Text format     Abstract available


  152. STETLER J, Karatasakis A, Christakopoulos GE, Tarar MN, et al
    Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Mar 25. doi: 10.1002/ccd.26505.
    PubMed     Text format     Abstract available


  153. KLEIN LW, Blankenship JC, Kolansky DM, Dean LS, et al
    SCAI position statement concerning coverage policies for percutaneous coronary interventions based on the appropriate use criteria.
    Catheter Cardiovasc Interv. 2016 Mar 10. doi: 10.1002/ccd.26499.
    PubMed     Text format    


  154. LATIB A, Pedersen W, Maisano F, Lesser J, et al
    Initial findings using the V8 hourglass-shaped valvuloplasty balloon for postdilatation in treating paravalvular leaks associated with transcatheter self-expanding aortic valve prosthesis.
    Catheter Cardiovasc Interv. 2016 Mar 6. doi: 10.1002/ccd.26462.
    PubMed     Text format     Abstract available


  155. IQBAL MB, Nadra IJ, Ding L, Fung A, et al
    Long-term outcomes following drug-eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real-world analysis of 11,181 patients from the british columbia cardiac registry.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26479.
    PubMed     Text format     Abstract available


  156. DU X, Pi Y, Dreyer RP, Li J, et al
    The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26461.
    PubMed     Text format     Abstract available


  157. SZERLIP M, Kim RJ, Adeniyi T, Thourani V, et al
    The outcomes of transcatheter aortic valve replacement in a cohort of patients with end-stage renal disease.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26347.
    PubMed     Text format     Abstract available


  158. KHAN AR, Khan S, Riaz H, Luni FK, et al
    Efficacy and safety of transcatheter aortic valve replacement in intermediate surgical risk patients: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26465.
    PubMed     Text format     Abstract available


  159. ROCKEFELLER T, Shahanavaz S, Zajarias A, Balzer D, et al
    Transcatheter implantation of SAPIEN 3 valve in native right ventricular outflow tract for severe pulmonary regurgitation following tetralogy of fallot repair.
    Catheter Cardiovasc Interv. 2016 Mar 4. doi: 10.1002/ccd.26480.
    PubMed     Text format     Abstract available


  160. MASTORIS I, Giustino G, Sartori S, Baber U, et al
    Efficacy and safety of routine thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An updated systematic review and meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2016;87:650-60.
    PubMed     Text format     Abstract available


  161. CONDADO JF, Block PC
    Is it really "paradoxical" or just the ventricle?
    Catheter Cardiovasc Interv. 2016;87:805-6.
    PubMed     Text format     Abstract available


  162. KARATASAKIS A, Brilakis ES
    Atherectomy for calcified coronary lesions: When and how?
    Catheter Cardiovasc Interv. 2016;87:701-2.
    PubMed     Text format     Abstract available


  163. CHANDRASEKHAR J, Mehran R
    Orbital atherectomy for severely calcified lesions: More dissections in women but similar 30-day outcomes to men.
    Catheter Cardiovasc Interv. 2016;87:678-9.
    PubMed     Text format     Abstract available


  164. BUTMAN SM
    Our aspirations still disappoint.
    Catheter Cardiovasc Interv. 2016;87:661-2.
    PubMed     Text format     Abstract available


  165. BLANKENSHIP JC
    When in doubt, aspirate.
    Catheter Cardiovasc Interv. 2016;87:648-9.
    PubMed     Text format     Abstract available


  166. CHEN X, Zhang D, Yin D, Li J, et al
    Can "true bifurcation lesion" actually be regarded as an independent risk factor of acute side branch occlusion after main vessel stenting?: A retrospective analysis of 1,200 consecutive bifurcation lesions in a single center.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:554-63.
    PubMed     Text format     Abstract available


  167. XU B, Qian J, Ge J, Wang J, et al
    Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
    Catheter Cardiovasc Interv. 2016;87 Suppl 1:624-9.
    PubMed     Text format     Abstract available


  168. TANAKA Y, Saito S
    Successful retrieval of a firmly stuck rotablator burr by using a modified STAR technique.
    Catheter Cardiovasc Interv. 2016;87:749-56.
    PubMed     Text format     Abstract available


  169. SECCO GG, Serdoz R, Kilic ID, Caiazzo G, et al
    Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience.
    Catheter Cardiovasc Interv. 2016;87:712-9.
    PubMed     Text format     Abstract available


  170. DE WAHA S, Allali A, Buttner HJ, Toelg R, et al
    Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.
    Catheter Cardiovasc Interv. 2016;87:691-700.
    PubMed     Text format     Abstract available


  171. GIUSTINO G, Baber U, Mastoris I, Vlachojannis GJ, et al
    One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Catheter Cardiovasc Interv. 2016;87:703-9.
    PubMed     Text format     Abstract available


  172. AMANN U, Kirchberger I, Heier M, von Scheidt W, et al
    Acute myocardial infarction in the elderly: Treatment strategies and 28-day-case fatality from the MONICA/KORA myocardial infarction registry.
    Catheter Cardiovasc Interv. 2016;87:680-8.
    PubMed     Text format     Abstract available


  173. VO MN, Karmpaliotis D, Brilakis ES
    "Move the cap" technique for ambiguous or impenetrable proximal cap of coronary total occlusion.
    Catheter Cardiovasc Interv. 2016;87:742-8.
    PubMed     Text format     Abstract available


  174. KIM CY, Lee AC, Wiedenbeck TL, Lee MS, et al
    Gender differences in acute and 30-day outcomes after orbital atherectomy treatment of de novo, severely calcified coronary lesions.
    Catheter Cardiovasc Interv. 2016;87:671-7.
    PubMed     Text format     Abstract available


  175. BOE BA, Bocks ML, Armstrong AK
    Contained rupture of patched right ventricular outflow tracts during balloon sizing for percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2016;87:768-72.
    PubMed     Text format     Abstract available


  176. ELEID MF, Asirvatham SJ, Cabalka AK, Hagler DJ, et al
    Transcatheter tricuspid valve-in-valve in patients with transvalvular device leads.
    Catheter Cardiovasc Interv. 2016;87:E160-5.
    PubMed     Text format     Abstract available


    February 2016
  177. PHILIP F, Stewart S, Southard JA
    Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
    Catheter Cardiovasc Interv. 2016 Feb 24. doi: 10.1002/ccd.26458.
    PubMed     Text format     Abstract available


  178. CHE WQ, Dong H, Jiang XJ, Peng M, et al
    Stenting for left subclavian artery stenosis in patients scheduled for left internal mammary artery-coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2016 Feb 23. doi: 10.1002/ccd.26477.
    PubMed     Text format     Abstract available


  179. RITTGER H, Wohrle J, Brachmann J, Hohenforst-Schmidt W, et al
    Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Catheter Cardiovasc Interv. 2016 Feb 19. doi: 10.1002/ccd.26451.
    PubMed     Text format     Abstract available


  180. WEBB JG, Dvir D
    Transcatheter valve implantation for calcific mitral valve disease.
    Catheter Cardiovasc Interv. 2016;87:549-50.
    PubMed     Text format     Abstract available


  181. BELARDI JA, Albertal M
    Acute kidney injury after TAVI: Predict, detect, and prevent.
    Catheter Cardiovasc Interv. 2016;87:532-3.
    PubMed     Text format     Abstract available


  182. HILLEGASS WB
    Risk-guided use of the direct thrombin inhibitor bivalirudin.
    Catheter Cardiovasc Interv. 2016;87:401-2.
    PubMed     Text format     Abstract available


  183. BADER Y, Kimmelstiel C
    Thrombin inhibition during PCI in heart failure patients.
    Catheter Cardiovasc Interv. 2016;87:374-5.
    PubMed     Text format     Abstract available


  184. PHILLIPS AB, Nevin P, Shah A, Olshove V, et al
    Development of a novel hybrid strategy for transcatheter pulmonary valve placement in patients following transannular patch repair of tetralogy of fallot.
    Catheter Cardiovasc Interv. 2016;87:403-10.
    PubMed     Text format     Abstract available


  185. CARDOSO R, Ansari M, Garcia D, Sandhu S, et al
    Prestenting for prevention of melody valve stent fractures: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2016;87:534-9.
    PubMed     Text format     Abstract available


  186. ABU HAZEEM A, Aldoss O, Fagan T
    A novel method to prevent recurrent balloon rupture during dilation of heavily calcified conduits in preparation for transcatheter pulmonary valve placement.
    Catheter Cardiovasc Interv. 2016;87:421-5.
    PubMed     Text format     Abstract available


  187. MULLER B, Ghawi H, Heitschmidt MG, Fogg L, et al
    Medium-term CT evaluation of stent geometry, integrity, and valve function of the Edwards SAPIEN transcatheter heart valve in the pulmonary position.
    Catheter Cardiovasc Interv. 2016;87:E97-103.
    PubMed     Text format     Abstract available


  188. CASADONTE JR, Wax DF, Gossett JG
    Extracardiac Fontan fenestration using the SafeSept transseptal guidewire and snare-controlled diabolo-shaped covered-stent placement.
    Catheter Cardiovasc Interv. 2016;87:426-31.
    PubMed     Text format     Abstract available


  189. SMOLKA G, Pysz P, Jasinski M, Roleder T, et al
    Multiplug paravalvular leak closure using Amplatzer Vascular Plugs III: A prospective registry.
    Catheter Cardiovasc Interv. 2016;87:478-87.
    PubMed     Text format     Abstract available


  190. SUGIYAMA H, Ishii T, Nakanishi T
    Successful coil embolization for Fontan-rout to aorta communication-recovery from complication of Brockenbrough procedure in Fontan patient.
    Catheter Cardiovasc Interv. 2016;87:E83-5.
    PubMed     Text format     Abstract available


  191. ZHANG Q, Hu J, Yang ZK, Ding FH, et al
    Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
    Catheter Cardiovasc Interv. 2016 Feb 10. doi: 10.1002/ccd.26406.
    PubMed     Text format     Abstract available


  192. LIAO YB, He ZX, Zhao ZG, Wei X, et al
    The relationship between chronic obstructive pulmonary disease and transcatheter aortic valve implantation-A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2016 Feb 9. doi: 10.1002/ccd.26443.
    PubMed     Text format     Abstract available


  193. KHAN R, Al-Hawwas M, Hatem R, Azzalini L, et al
    Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2016 Feb 1. doi: 10.1002/ccd.26413.
    PubMed     Text format     Abstract available


  194. ECHEVERRIA A, Krajcer Z
    Vascular complications in steroid treated patients undergoing trans-femoral aortic valve implantation.
    Catheter Cardiovasc Interv. 2016;87:347-8.
    PubMed     Text format     Abstract available


  195. KORNOWSKI R
    The alternative approach to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016;87:339-40.
    PubMed     Text format     Abstract available


  196. SAFIAN RD
    Restenosis after PCI: Battered but not beaten.
    Catheter Cardiovasc Interv. 2016;87:209-10.
    PubMed     Text format    


  197. GEIR SOLBERG O, Aaberge L, Ragnarsson A, Aas M, et al
    Comparison of simplified and comprehensive methods for assessing the index of microvascular resistance in heart transplant recipients.
    Catheter Cardiovasc Interv. 2016;87:283-90.
    PubMed     Text format     Abstract available


    January 2016
  198. DONG H, Jiang X, Peng M, Zou Y, et al
    The interval between carotid artery stenting and open heart surgery is related to perioperative complications.
    Catheter Cardiovasc Interv. 2016 Jan 26. doi: 10.1002/ccd.26408.
    PubMed     Text format     Abstract available


  199. TOKAREK T, Siudak Z, Dziewierz A, Sobczynski R, et al
    Assessment of quality of life in patients after surgical and transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Jan 23. doi: 10.1002/ccd.26400.
    PubMed     Text format     Abstract available


  200. BEN-YEHUDA O, Kazi DS, Bonafede M, Wade SW, et al
    Angina and associated healthcare costs following percutaneous coronary intervention: A real-world analysis from a multi-payer database.
    Catheter Cardiovasc Interv. 2016 Jan 17. doi: 10.1002/ccd.26365.
    PubMed     Text format     Abstract available


  201. CERILLO AG, Griese D, Berti S
    Successful percutaneous implantation of symetis ACURATE neo transcatheter aortic bioprosthesis for the treatment of pure aortic regurgitation.
    Catheter Cardiovasc Interv. 2016 Jan 13. doi: 10.1002/ccd.26402.
    PubMed     Text format     Abstract available


  202. LEE MS, Yang T, Lasala J, Cox D, et al
    Impact of coronary artery calcification in percutaneous coronary intervention with paclitaxel-eluting stents: Two-year clinical outcomes of paclitaxel-eluting stents in patients from the ARRIVE program.
    Catheter Cardiovasc Interv. 2016 Jan 12. doi: 10.1002/ccd.26395.
    PubMed     Text format     Abstract available


  203. ABRAMOWITZ Y, Chakravarty T, Jilaihawi H, Cox J, et al
    Impact of body mass index on the outcomes following transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2016 Jan 12. doi: 10.1002/ccd.26394.
    PubMed     Text format     Abstract available


  204. HILLEGASS WB
    Insulin-treated diabetes mellitus: An important, actionable risk marker after coronary stenting.
    Catheter Cardiovasc Interv. 2016;87:63-4.
    PubMed     Text format     Abstract available


  205. TOMMASO CL
    Learning curves for TAVR: Not quite see one, do one teach one.
    Catheter Cardiovasc Interv. 2016;87:163-4.
    PubMed     Text format     Abstract available


  206. CILINGIROGLU M, Marmagkiolis K
    A glimpse into the future of TAVR.
    Catheter Cardiovasc Interv. 2016;87:152-3.
    PubMed     Text format     Abstract available


  207. CHANDRASEKHAR J, Mehran R
    Same or next day discharge: A new chapter in transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2016;87:143-4.
    PubMed     Text format     Abstract available


  208. BANG VV, Levy MS
    In multivessel coronary artery disease, a "state-of-the-art" randomized clinical trial of revascularization is needed.
    Catheter Cardiovasc Interv. 2016;87:13-4.
    PubMed     Text format     Abstract available


  209. HOLZER RJ, Hijazi ZM
    Transcatheter pulmonary valve replacement: State of the art.
    Catheter Cardiovasc Interv. 2016;87:117-28.
    PubMed     Text format     Abstract available


  210. HERMUZI A, McBrien A, De Rita F, McCheyne A, et al
    Hybrid transatrial stent insertion for left atrial decompression in hypoplastic left heart syndrome with intact atrial septum.
    Catheter Cardiovasc Interv. 2016;87:109-16.
    PubMed     Text format     Abstract available


  211. KITANO M, Yazaki S, Kagisaki K
    Ductal stenting using side-branch cell dilation for aortic coarctation in high-risk patients with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2016;87:E23-9.
    PubMed     Text format     Abstract available


  212. CRUZ-GONZALEZ I, Palazuelos Molinero J, Valenzuela M, Rada I, et al
    Brain natriuretic peptide levels variation after left atrial appendage occlusion.
    Catheter Cardiovasc Interv. 2016;87:E39-43.
    PubMed     Text format     Abstract available


  213. KATOH H, Nozue T, Michishita I
    A case of giant saphenous vein graft aneurysm successfully treated with catheter intervention.
    Catheter Cardiovasc Interv. 2016;87:83-9.
    PubMed     Text format     Abstract available


  214. NOAD RL, Johnston N, McKinley A, Dougherty M, et al
    A pathway to earlier discharge following TAVI: Assessment of safety and resource utilization.
    Catheter Cardiovasc Interv. 2016;87:134-42.
    PubMed     Text format     Abstract available


  215. ZIMARINO M, Ricci F, Romanello M, Di Nicola M, et al
    Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.
    Catheter Cardiovasc Interv. 2016;87:3-12.
    PubMed     Text format     Abstract available


  216. ROSS MM, Schamberger MS, Hoyer MH
    Resolution of inferior venous baffle leak and total venous occlusion using a bare stent and the gore((R)) excluder( (R)) aortic extension in transposition of the great arteries after mustard procedure.
    Catheter Cardiovasc Interv. 2016;87:E19-22.
    PubMed     Text format     Abstract available


    December 2015
  217. HABARA M, Tsuchikane E, Muramatsu T, Kashima Y, et al
    Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry.
    Catheter Cardiovasc Interv. 2015 Dec 31. doi: 10.1002/ccd.26354.
    PubMed     Text format     Abstract available


  218. KOIFMAN E, Kiramijyan S, Negi SI, Didier R, et al
    Body mass index association with survival in severe aortic stenosis patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2015 Dec 30. doi: 10.1002/ccd.26377.
    PubMed     Text format     Abstract available


  219. LEE KS, Lee JZ, Hsu CH, Husnain M, et al
    Temporal Trends in Strut-Level Optical Coherence Tomography Evaluation of Coronary Stent Coverage: A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2015 Dec 28. doi: 10.1002/ccd.26374.
    PubMed     Text format     Abstract available


  220. VIDI VD, Barseghian A, Garratt KN
    Multivessel percutaneous coronary intervention without contrast agents.
    Catheter Cardiovasc Interv. 2015 Dec 28. doi: 10.1002/ccd.26370.
    PubMed     Text format     Abstract available


  221. DOMINGUEZ AC, Bittl JA, El-Hayek G, Contreras E, et al
    Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26352.
    PubMed     Text format     Abstract available


  222. CHEN SH, Ho KK, Gannon SA, Thyagarajan B, et al
    Utility of a real-time appropriate use criteria decision support application for percutaneous coronary interventions in non-acute coronary syndrome.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26350.
    PubMed     Text format     Abstract available


  223. DERY JP, Mahaffey KW, Tricoci P, White HD, et al
    Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26335.
    PubMed     Text format     Abstract available


  224. WATERBURY TM, Sorajja P, Bell MR, Lennon RJ, et al
    Experience and complications associated with use of guide extension catheters in percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26329.
    PubMed     Text format     Abstract available


  225. THAKKAR B, Patel A, Mohamad B, Patel NJ, et al
    Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis.
    Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26345.
    PubMed     Text format     Abstract available


  226. PASS RH
    Letter regarding: Bronchoscopic guidance of endovascular stenting limits airway compression.
    Catheter Cardiovasc Interv. 2015;86:1299.
    PubMed     Text format    


  227. EL-SAID H
    Rebuttal.
    Catheter Cardiovasc Interv. 2015;86:1300-1.
    PubMed     Text format    


  228. FELDMAN T, Reardon MJ
    Mitral valve-in-valve with the lotus mechanically expanding platform.
    Catheter Cardiovasc Interv. 2015;86:1287-1288.
    PubMed     Text format     Abstract available


    November 2015
  229. MONT'ALVERNE-FILHO JR, Rodrigues-Sobrinho CR, Medeiros F, Falcao FC, et al
    Upstream clopidogrel, prasugrel, or ticagrelor for patients treated with primary angioplasty: Results of an angiographic randomized pilot study.
    Catheter Cardiovasc Interv. 2015 Nov 28. doi: 10.1002/ccd.26334.
    PubMed     Text format     Abstract available


  230. NASCIMBENE A, Loyalka P, Gregoric ID, Kar B, et al
    Percutaneous coronary intervention with the TandemHeart percutaneous left ventricular assist device support: Six years of experience and outcomes.
    Catheter Cardiovasc Interv. 2015 Nov 21. doi: 10.1002/ccd.26147.
    PubMed     Text format     Abstract available


  231. LARMORE C, Effron MB, Molife C, DeKoven M, et al
    "Real-World" comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States.
    Catheter Cardiovasc Interv. 2015 Nov 18. doi: 10.1002/ccd.26279.
    PubMed     Text format     Abstract available


  232. PURI R, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F, et al
    Transcatheter mitral valve implantation for inoperable severely calcified native mitral valve disease: A systematic review.
    Catheter Cardiovasc Interv. 2015 Nov 18. doi: 10.1002/ccd.26262.
    PubMed     Text format     Abstract available


  233. KIM SM, Moliterno DJ
    Ageless benefits of transradial access for percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2015;86:973-4.
    PubMed     Text format     Abstract available


  234. YOSHIMACHI F, Torii S, Naito T
    A novel percutaneous coronary intervention technique for chronic total occlusion: Contralateral angiography with a single guiding catheter.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26268.
    PubMed     Text format     Abstract available


  235. SANCHEZ CE, Dota A, Badhwar V, Kliner D, et al
    Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26276.
    PubMed     Text format     Abstract available


  236. NDREPEPA G, Groha P, Lahmann AL, Lohaus R, et al
    Increased bleeding risk during percutaneous coronary interventions by arterial hypertension.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26272.
    PubMed     Text format     Abstract available


  237. PINEDA AM, Chandra R, Gowani SA, Santana O, et al
    Completeness of revascularization and its impact on the outcomes of a staged approach of percutaneous coronary intervention followed by minimally invasive valve surgery for patients with concomitant coronary artery and valvular heart disease.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26294.
    PubMed     Text format     Abstract available


  238. JANG WJ, Yang JH, Choi SH, Song YB, et al
    Association of periprocedural myocardial infarction with long-term survival in patients treated with coronary revascularization therapy of chronic total occlusion.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26286.
    PubMed     Text format     Abstract available


  239. ELGENDY IY, Wen X, Mahmoud A, Bavry AA, et al
    Complete versus culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: An updated meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26322.
    PubMed     Text format     Abstract available


  240. ABRAMOWITZ Y, Jilaihawi H, Chakravarty T, Kashif M, et al
    Balloon-expandable transcatheter aortic valve replacement in patients with extreme aortic valve calcification.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26311.
    PubMed     Text format     Abstract available


  241. HALKIN A, Steinvil A, Aviram G, Biner S, et al
    Aortic regurgitation following transcatheter aortic valve replacement: Impact of preprocedural left ventricular diastolic filling patterns on late clinical outcomes.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26298.
    PubMed     Text format     Abstract available


  242. BELARDI JA, Albertal M
    Transcatheter aortic valve implantation: Watch out for the leak, irrespective of aortic valve disease type.
    Catheter Cardiovasc Interv. 2015;86:886-7.
    PubMed     Text format     Abstract available


  243. LUCAS V
    "I see the light!" trans-carotid balloon valvuloplasty in neonates and small infants utilizing continuous trans-esophageal echo guidance.
    Catheter Cardiovasc Interv. 2015;86:828.
    PubMed     Text format     Abstract available


    October 2015
  244. KRISHNASWAMY A, Latib A, Malik A, Bertoldi L, et al
    Resource utilization for transfemoral transcatheter aortic valve replacement: An international comparison.
    Catheter Cardiovasc Interv. 2015 Oct 28. doi: 10.1002/ccd.26056.
    PubMed     Text format     Abstract available


  245. REINOHL J, Psyrakis D, Kaier K, Kodirov S, et al
    Aortic root volume is associated with contained rupture of the aortic annulus in balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2015 Oct 26. doi: 10.1002/ccd.26260.
    PubMed     Text format     Abstract available


  246. BAPAT V, Pirone F, Kapetanakis S, Rajani R, et al
    Factors influencing left ventricular outflow tract obstruction following a mitral valve-in-valve or valve-in-ring procedure, part 1.
    Catheter Cardiovasc Interv. 2015;86:747-760.
    PubMed     Text format     Abstract available


  247. JATENE T, Bhatt DL
    TAVR in patients with severe aortic stenosis and less than high risk: Future or present reality?
    Catheter Cardiovasc Interv. 2015;86:745-746.
    PubMed     Text format     Abstract available


  248. DEBRY N, Sudre A, Amr G, Delhaye C, et al
    Transcatheter aortic valve implantation for paradoxical low-flow low-gradient aortic stenosis patients.
    Catheter Cardiovasc Interv. 2015 Oct 1. doi: 10.1002/ccd.26253.
    PubMed     Text format     Abstract available


  249. MINHA S, Waksman R, Satler LP, Torguson R, et al
    Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Success and safety.
    Catheter Cardiovasc Interv. 2015 Oct 1. doi: 10.1002/ccd.26121.
    PubMed     Text format     Abstract available


  250. CABASA AS, Eleid MF, Suri RM
    Transcatheter aortic valve replacement for native aortic valve regurgitation as a bridge to liver transplantation.
    Catheter Cardiovasc Interv. 2015 Oct 1. doi: 10.1002/ccd.26264.
    PubMed     Text format     Abstract available


    September 2015
  251. LEDERMAN RJ, Babaliaros VC, Greenbaum AB
    How to perform transcaval access and closure for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 Sep 10. doi: 10.1002/ccd.26141.
    PubMed     Text format     Abstract available


  252. SINGH RAO R, Shapiro RL, Lasala JM
    No reflow leading to catastrophic hemodynamic collapse in a patient with severe aortic stenosis and its management.
    Catheter Cardiovasc Interv. 2015 Sep 10. doi: 10.1002/ccd.26233.
    PubMed     Text format     Abstract available


  253. SALEH N, De Palma R, Settergren M, Ruck A, et al
    Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Catheter Cardiovasc Interv. 2015 Sep 2. doi: 10.1002/ccd.25966.
    PubMed     Text format     Abstract available


  254. KHEIWA A, Turner D, Schreiber T
    Left main coronary artery embolization in an 11-year-old girl due to inflammatory myofibroblastic tumor of the mitral valve.
    Catheter Cardiovasc Interv. 2015 Sep 2. doi: 10.1002/ccd.26149.
    PubMed     Text format     Abstract available


    August 2015
  255. TRUONG UT, Fagan TE, Deterding R, Ing RJ, et al
    Use of rotational angiography in assessing relationship of the airway to vasculature during cardiac catheterization.
    Catheter Cardiovasc Interv. 2015 Aug 17. doi: 10.1002/ccd.26004.
    PubMed     Text format     Abstract available


  256. KOIFMAN E, Segev A, Fefer P, Barbash I, et al
    Comparison of acute kidney injury classifications in patients undergoing transcatheter aortic valve implantation: Predictors and long-term outcomes.
    Catheter Cardiovasc Interv. 2015 Aug 13. doi: 10.1002/ccd.26138.
    PubMed     Text format     Abstract available


  257. TRIANTAFYLLIS AS, Kortlandt F, Bakker AL, Swaans MJ, et al
    Long-term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2015 Aug 13. doi: 10.1002/ccd.26137.
    PubMed     Text format     Abstract available


  258. BASIR MB, Velez C, Fuller B, Wyman J, et al
    Rates of vascular access use in transcatheter aortic valve replacement: A look into the next generation.
    Catheter Cardiovasc Interv. 2015 Aug 10. doi: 10.1002/ccd.26116.
    PubMed     Text format     Abstract available


  259. ESCARCEGA RO, Magalhaes MA, Baker NC, Lipinski MJ, et al
    Does the disparity in baseline characteristics of patients undergoing transcatheter aortic valve replacement with 23 mm vs. 26 mm valves impact clinical outcome?
    Catheter Cardiovasc Interv. 2015 Aug 10. doi: 10.1002/ccd.25967.
    PubMed     Text format     Abstract available


  260. ALLI O, Rihal CS, Suri RM, Greason KL, et al
    Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance.
    Catheter Cardiovasc Interv. 2015 Aug 10. doi: 10.1002/ccd.26120.
    PubMed     Text format     Abstract available


  261. HAMDAN A, Kornowski R
    Transcatheter aortic valve implantation for bicuspid aortic valve stenosis.
    Catheter Cardiovasc Interv. 2015;86:331-3.
    PubMed     Text format     Abstract available


    July 2015
  262. GENEREUX P, Demers P, Poulin F
    Same day discharge after transcatheter aortic valve replacement: Are we there yet?
    Catheter Cardiovasc Interv. 2015 Jul 21. doi: 10.1002/ccd.26059.
    PubMed     Text format     Abstract available


  263. ANGELINI P, Uribe C, Monge J, Tobis JM, et al
    Origin of the right coronary artery from the opposite sinus of Valsalva in adults: Characterization by intravascular ultrasonography at baseline and after stent angioplasty.
    Catheter Cardiovasc Interv. 2015 Jul 14. doi: 10.1002/ccd.26069.
    PubMed     Text format     Abstract available


  264. SHIVARAJU A, Ott I, Cassese S, Bourier F, et al
    Fluoroscopic calcification-guided optimal deployment projection during transcatheter aortic valve replacement-"The eye of the pigtail."(Follow the right cusp rule-Part II).
    Catheter Cardiovasc Interv. 2015 Jul 14. doi: 10.1002/ccd.25929.
    PubMed     Text format    


  265. KRISHNASWAMY A, Tuzcu EM
    Predicting paravalvular leak after balloon-expandable TAVR.
    Catheter Cardiovasc Interv. 2015;86:152-3.
    PubMed     Text format     Abstract available


  266. SETO AH, Kern MJ
    Is the left main just another artery to FFR?
    Catheter Cardiovasc Interv. 2015;86:19-20.
    PubMed     Text format     Abstract available


  267. MEIER B
    Percutaneous closure of the patent foramen ovale, easy does it.
    Catheter Cardiovasc Interv. 2015;86:113-4.
    PubMed     Text format     Abstract available


  268. TREMMEL JA, Bhatt DL, Pinto DS, Grines CL, et al
    Late breaking trials of 2014 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
    Catheter Cardiovasc Interv. 2015;86:73-9.
    PubMed     Text format     Abstract available


  269. CILINGIROGLU M, Patel RA, Dean LS
    Late breaking trials of 2014 in structural heart disease and peripheral arterial disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA.
    Catheter Cardiovasc Interv. 2015;86:80-4.
    PubMed     Text format     Abstract available


  270. HIJAZI ZM, Ruiz CE, Zahn E, Ringel R, et al
    SCAI/AATS/ACC/STS operator and institutional requirements for transcatheter valve repair and replacement, Part III: Pulmonic valve.
    Catheter Cardiovasc Interv. 2015;86:85-93.
    PubMed     Text format     Abstract available


  271. NARAYAN SA, Elmahdi E, Rosenthal E, Qureshi SA, et al
    Long-term follow-up is not indicated after routine interventional closure of persistent arterial ducts.
    Catheter Cardiovasc Interv. 2015;86:100-4.
    PubMed     Text format     Abstract available


  272. AMINIAN A, Lalmand J, Tzikas A, Budts W, et al
    Embolization of left atrial appendage closure devices: A systematic review of cases reported with the watchman device and the amplatzer cardiac plug.
    Catheter Cardiovasc Interv. 2015;86:128-35.
    PubMed     Text format     Abstract available


  273. ABDELBASIT MA, Alwi M, Kandavello G, Che Mood M, et al
    The new Occlutech(R) PDA occluder: Initial human experience.
    Catheter Cardiovasc Interv. 2015;86:94-9.
    PubMed     Text format     Abstract available


  274. MANGIERI A, Godino C, Montorfano M, Arioli F, et al
    PFO closure with only fluoroscopic guidance: 7 years real-world single centre experience.
    Catheter Cardiovasc Interv. 2015;86:105-12.
    PubMed     Text format     Abstract available


    June 2015
  275. COCKBURN J, Singh MS, Rafi NH, Dooley M, et al
    Poor mobility predicts adverse outcome better than other frailty indices in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 Jun 29. doi: 10.1002/ccd.25991.
    PubMed     Text format     Abstract available


  276. SAJI M, Rossi AM, Ailawadi G, Dent J, et al
    Adjunctive intracardiac echocardiography imaging from the left ventricle to guide percutaneous mitral valve repair with the mitraclip in patients with failed prior surgical rings.
    Catheter Cardiovasc Interv. 2015 Jun 23. doi: 10.1002/ccd.25981.
    PubMed     Text format     Abstract available


  277. WOHRLE J, Rodewald C, Rottbauer W
    Transfemoral aortic valve implantation in pure native aortic valve insufficiency using the repositionable and retrievable lotus valve.
    Catheter Cardiovasc Interv. 2015 Jun 23. doi: 10.1002/ccd.26062.
    PubMed     Text format     Abstract available


  278. KRISHNASWAMY A, Tuzcu EM
    Minimizing acute kidney injury during TAVR: The Importance of Seeing the Trees and the Forest.
    Catheter Cardiovasc Interv. 2015;85:1254-5.
    PubMed     Text format    


  279. COLOMBO A, Ruparelia N
    Experience and accuracy can result in parity of outcomes following one or two stents for left main stem bifurcation disease.
    Catheter Cardiovasc Interv. 2015;85:1139-40.
    PubMed     Text format    


  280. HOSHINO S, Kitano M, Abe T, Yazaki S, et al
    Efficacy and safety of percutaneous transluminal balloon dilation to prevent progression of banding site stenosis after bilateral pulmonary artery banding.
    Catheter Cardiovasc Interv. 2015;85:E197-202.
    PubMed     Text format     Abstract available


  281. GAO Z, Xu B, Yang Y, Qiao S, et al
    Comparison between one-stent versus two-stent technique for treatment of left main bifurcation lesions: A large single-center data.
    Catheter Cardiovasc Interv. 2015;85:1132-8.
    PubMed     Text format     Abstract available


  282. WIEBE J, Hamm C, Nef H
    A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable.
    Catheter Cardiovasc Interv. 2015;85:1184-8.
    PubMed     Text format     Abstract available


  283. ZHANG Y, Pyxaras SA, Wolf A, Schmitz T, et al
    Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
    Catheter Cardiovasc Interv. 2015;85:1217-25.
    PubMed     Text format     Abstract available


  284. LEDERMAN RJ, O'Neill WW, Greenbaum AB
    Transcaval access for TAVR across a polyester aortic graft.
    Catheter Cardiovasc Interv. 2015;85:1270-3.
    PubMed     Text format     Abstract available


  285. DANSON EJ, Ward M
    Retrieval of a subintimal fractured guide wire from the brachial artery following saphenous vein graft stenting.
    Catheter Cardiovasc Interv. 2015;85:E171-4.
    PubMed     Text format     Abstract available


  286. SILVA GV, Gahremanpour A, Attizzani GF, Zeng Y, et al
    Comparison of scanning electron microscopy and optical coherence tomography for imaging of coronary bifurcation stents.
    Catheter Cardiovasc Interv. 2015;85:1141-9.
    PubMed     Text format     Abstract available


  287. SHARMA D, Ramsewak A, O'Conaire S, Manoharan G, et al
    Reducing radiation exposure during transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2015;85:1256-61.
    PubMed     Text format     Abstract available


  288. NOONAN PM, Taliotis D, Alahmar A
    Percutaneous coronary intervention in a 3-year-old with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2015;85:1209-11.
    PubMed     Text format     Abstract available


    May 2015
  289. CHIEFFO A, Van Mieghem NM, Tchetche D, Dumonteil N, et al
    Impact of mixed aortic valve stenosis on VARC-2 outcomes and postprocedural aortic regurgitation in patients undergoing transcatheter aortic valve implantation: Results from the international multicentric study PRAGMATIC (pooled Rotterdam-Milan-Toulou
    Catheter Cardiovasc Interv. 2015 May 29. doi: 10.1002/ccd.25975.
    PubMed     Text format     Abstract available


  290. SEDAGHAT A, Al-Rashid F, Sinning JM, Wendt D, et al
    Outcome in TAVI patients with symptomatic aortic stenosis not fulfilling PARTNER study inclusion criteria.
    Catheter Cardiovasc Interv. 2015 May 29. doi: 10.1002/ccd.25950.
    PubMed     Text format     Abstract available


  291. KISCHE S, D'Ancona G, Agma HU, Gurer H, et al
    Transcatheter, inflatable, and fully repositionable aortic valve: Preliminary results using a modified implantation technique.
    Catheter Cardiovasc Interv. 2015 May 27. doi: 10.1002/ccd.26039.
    PubMed     Text format     Abstract available


  292. FINK N, Segev A, Barbash I, Bogdan A, et al
    Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 May 23. doi: 10.1002/ccd.26014.
    PubMed     Text format     Abstract available


  293. BITTL JA, Tamis-Holland JE, Lang CD, He Y, et al
    Outcomes after multivessel or culprit-Vessel intervention for ST-elevation myocardial infarction in patients with multivessel coronary disease: A Bayesian cross-design meta-analysis.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.26025.
    PubMed     Text format     Abstract available


  294. DAUTOV R, Abdul Jawad Altisent O, Rinfret S
    Stumpless chronic total occlusion with no retrograde option: Multidetector Computed Tomography-Guided Intervention via Bi-Radial Approach Utilizing Bioresorbable Vascular Scaffold.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.25938.
    PubMed     Text format     Abstract available


  295. CONDADO J, Leonardi R, Babaliaros V
    Percutaneous tricuspid valve-In-ring replacement for the treatment of recurrent severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.25980.
    PubMed     Text format     Abstract available


  296. CIUCA C, Tarantini G, Latib A, Gasparetto V, et al
    Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study.
    Catheter Cardiovasc Interv. 2015 May 22. doi: 10.1002/ccd.26012.
    PubMed     Text format     Abstract available


  297. COLLAS VM, Dubois C, Legrand V, Kefer J, et al
    Midterm clinical outcome following Edwards SAPIEN or Medtronic Corevalve transcatheter aortic valve implantation (TAVI): Results of the Belgian TAVI registry.
    Catheter Cardiovasc Interv. 2015 May 11. doi: 10.1002/ccd.25999.
    PubMed     Text format     Abstract available


  298. WATANABE Y, Lefevre T, Bouvier E, Arai T, et al
    Prognostic value of aortic root calcification volume on clinical outcomes after transcatheter balloon-expandable aortic valve implantation.
    Catheter Cardiovasc Interv. 2015 May 6. doi: 10.1002/ccd.25986.
    PubMed     Text format     Abstract available


  299. GILCHRIST IC
    Association of embolism and stroke in the catheterization laboratory.
    Catheter Cardiovasc Interv. 2015;85:1041-2.
    PubMed     Text format    


  300. CHAMBERS CE
    SCAI: home of interventional cardiology.
    Catheter Cardiovasc Interv. 2015;85:941-3.
    PubMed     Text format    


  301. DILETTI R, Garcia-Garcia HM, Bourantas C, Van Mieghem NM, et al
    Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program.
    Catheter Cardiovasc Interv. 2015;85:952-8.
    PubMed     Text format     Abstract available


  302. KANG SL, Tometzki A, Caputo M, Morgan G, et al
    Longer-term outcome of perventricular device closure of muscular ventricular septal defects in children.
    Catheter Cardiovasc Interv. 2015;85:998-1005.
    PubMed     Text format     Abstract available


    April 2015
  303. PHILIP F, Faza NN, Schoenhagen P, Desai MY, et al
    Aortic annulus and root characteristics in severe aortic stenosis due to bicuspid aortic valve and tricuspid aortic valves: Implications for transcatheter aortic valve therapies.
    Catheter Cardiovasc Interv. 2015 Apr 24. doi: 10.1002/ccd.25948.
    PubMed     Text format     Abstract available


  304. LIM W, Smith T, Rogers JH
    Transcatheter repair of aortic leaflet perforation in a patient with prior surgical bicuspid aortic valve repair.
    Catheter Cardiovasc Interv. 2015 Apr 24. doi: 10.1002/ccd.25958.
    PubMed     Text format     Abstract available


  305. RASSAF T, Balzer J, Rammos C, Zeus T, et al
    Influence of percutaneous mitral valve repair using the MitraClip(R) system on renal function in patients with severe mitral regurgitation.
    Catheter Cardiovasc Interv. 2015;85:899-903.
    PubMed     Text format     Abstract available


  306. CILINGIROGLU M, Marmagkiolis K
    Should MitraClip be preferred over surgery in high-risk patients with severe MR and CKD?
    Catheter Cardiovasc Interv. 2015;85:904-5.
    PubMed     Text format     Abstract available


  307. HOUSER L, Zaragoza-Macias E, Jones TK, Aboulhosn J, et al
    Transcatheter closure of atrial septal communication during pregnancy in women with Ebstein's anomaly of the tricuspid valve and cyanosis.
    Catheter Cardiovasc Interv. 2015;85:842-6.
    PubMed     Text format     Abstract available


  308. EBRAHIM M, Hagood J, Moore J, El-Said H, et al
    Bronchoscopic guidance of endovascular stenting limits airway compression.
    Catheter Cardiovasc Interv. 2015;85:832-6.
    PubMed     Text format     Abstract available


  309. MCCROSSAN BA, Walsh KP
    Fontan fenestration closure with Amplatzer Duct Occluder II device.
    Catheter Cardiovasc Interv. 2015;85:837-41.
    PubMed     Text format     Abstract available


  310. ABOU ZAHR R, Hellenbrand WE, Asnes JD
    Iatrogenic left pulmonary artery to left atrium fistula.
    Catheter Cardiovasc Interv. 2015;85:847-9.
    PubMed     Text format     Abstract available


  311. KUO JA
    Percutaneous device occlusion of hepatocardiac venous collateral via left transhepatic access in a patient with heterotaxy syndrome following Fontan procedure.
    Catheter Cardiovasc Interv. 2015;85:E140-3.
    PubMed     Text format     Abstract available


  312. JONES BM, Tuzcu EM, Kapadia SR
    Pushing with the pigtail: a novel approach to placing the MitraClip in a patient with a severely restricted posterior mitral leaflet.
    Catheter Cardiovasc Interv. 2015;85:906-8.
    PubMed     Text format     Abstract available


    March 2015
  313. ASHIKAGA T, Yoshikawa S, Isobe M
    The effectiveness of excimer laser coronary atherectomy with contrast medium for under-expanded stent; The findings of optical frequency domain imaging.
    Catheter Cardiovasc Interv. 2015 Mar 7. doi: 10.1002/ccd.25915.
    PubMed     Text format     Abstract available


  314. BLOCK PC
    Evolving TAVR, and the need for intelligent design.
    Catheter Cardiovasc Interv. 2015;85:655-6.
    PubMed     Text format    


  315. JALAL Z, Malekzadeh-Milani S, Hofbeck M, Al Najashi K, et al
    A new percutaneous pulmonary valve implantation technique for complex right ventricular outflow tracts: the "folded melody valve".
    Catheter Cardiovasc Interv. 2015;85:604-10.
    PubMed     Text format     Abstract available


  316. DEHGHANI P, Kraushaar G, Taylor DA
    Coronary artery compression three months after transcatheter pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2015;85:611-4.
    PubMed     Text format     Abstract available


  317. HADDAD LM, Magill HL, Sathanandam SK
    Management of anomalous circumflex coronary artery from the neo-pulmonary artery in an adolescent following neonatal arterial switch operation.
    Catheter Cardiovasc Interv. 2015;85:625-8.
    PubMed     Text format     Abstract available


  318. BAPAT V, Adams B, Attia R, Noorani A, et al
    Neo-annulus: a reference plane in a surgical heart valve to facilitate a valve-in-valve procedure.
    Catheter Cardiovasc Interv. 2015;85:685-91.
    PubMed     Text format     Abstract available


    February 2015
  319. MALLIDI J, Atreya AR, Cook J, Garb J, et al
    Long term outcomes following fractional flow reserve guided treatment of angiographically ambiguous left main coronary artery disease: A meta- analysis of prospective cohort studies.
    Catheter Cardiovasc Interv. 2015 Feb 11. doi: 10.1002/ccd.25894.
    PubMed     Text format     Abstract available


    January 2015
  320. MALLULA K, Vaughn G, El-Said H, Lamberti JJ, et al
    Comparison of ductal stenting versus surgical shunts for palliation of patients with pulmonary atresia and intact ventricular septum.
    Catheter Cardiovasc Interv. 2015 Jan 30. doi: 10.1002/ccd.25870.
    PubMed     Text format     Abstract available


  321. GARGIULO G, Sannino A, Capodanno D, Perrino C, et al
    Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta-analysis of 5,971 patients.
    Catheter Cardiovasc Interv. 2015 Jan 30. doi: 10.1002/ccd.25867.
    PubMed     Text format     Abstract available


  322. JILAIHAWI H, Wu Y, Yang Y, Xu L, et al
    Morphological characteristics of severe aortic stenosis in China: Imaging corelab observations from the first Chinese transcatheter aortic valve trial.
    Catheter Cardiovasc Interv. 2015 Jan 29. doi: 10.1002/ccd.25863.
    PubMed     Text format     Abstract available


  323. BUGAN B, Kapadia S, Svensson L, Krishnaswamy A, et al
    Novel hemodynamic index for assessment of aortic regurgitation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2015 Jan 22. doi: 10.1002/ccd.25848.
    PubMed     Text format     Abstract available


  324. BIASCO L, De Backer O, Holme S, Sondergaard L, et al
    The "chimney approach" for transcatheter aortic valve implantation: a strategy for trans axillarian bareback approach in patients with no other access options.
    Catheter Cardiovasc Interv. 2015 Jan 19. doi: 10.1002/ccd.25840.
    PubMed     Text format     Abstract available


  325. ARAI T, Morice MC, O'Connor SA, Yamamoto M, et al
    Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry).
    Catheter Cardiovasc Interv. 2015 Jan 13. doi: 10.1002/ccd.25832.
    PubMed     Text format     Abstract available


  326. BERNARDI FL, Gomes WF, de Brito FS, Mangione JA, et al
    Surgical cutdown versus percutaneous access in transfemoral transcatheter aortic valve implantation: Insights from the Brazilian TAVI registry.
    Catheter Cardiovasc Interv. 2015 Jan 13. doi: 10.1002/ccd.25820.
    PubMed     Text format     Abstract available


  327. SINGH M, Mishra A, Kaluski E
    Acute ST-Elevation Myocardial Infarction due to Septic Embolism: A Case Report and Review of Management Options.
    Catheter Cardiovasc Interv. 2015 Jan 9. doi: 10.1002/ccd.25829.
    PubMed     Text format     Abstract available


  328. DVIR D, Webb JG, Piazza N, Blanke P, et al
    Multicenter Evaluation of Transcatheter Aortic Valve Replacement Using either SAPIEN XT or CoreValve: Degree of Device Oversizing by Computed-Tomography and Clinical Outcomes.
    Catheter Cardiovasc Interv. 2015 Jan 9. doi: 10.1002/ccd.25823.
    PubMed     Text format     Abstract available


  329. MOUILLET G, Lellouche N, Yamamoto M, Oguri A, et al
    Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve devices: Results from the FRANCE 2 Registry.
    Catheter Cardiovasc Interv. 2015 Jan 8. doi: 10.1002/ccd.25818.
    PubMed     Text format     Abstract available


    December 2014
  330. ARRIGO M, Maisano F, Haueis S, Binder RK, et al
    Transcatheter aortic-valve implantation with one single minimal contrast media injection.
    Catheter Cardiovasc Interv. 2014 Dec 24. doi: 10.1002/ccd.25799.
    PubMed     Text format     Abstract available


  331. CHAN YH, Stella PR, Agostoni P
    A "simplified" culotte technique using two dedicated bifurcation stents and additional angiographic stent enhancement to treat a complex bifurcation lesion in non-ST segment elevation myocardial infarction with poor left ventricular function.
    Catheter Cardiovasc Interv. 2014 Dec 22. doi: 10.1002/ccd.25795.
    PubMed     Text format     Abstract available


  332. ELLING R, Stiller B, Grohmann J
    Transcatheter device occlusion of the left ventricular outflow tract as treatment for severe aortic regurgitation in hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2014 Dec 22. doi: 10.1002/ccd.25782.
    PubMed     Text format     Abstract available


  333. DE BRITO FS, Carvalho LA, Sarmento-Leite R, Mangione JA, et al
    Outcomes and predictors of mortality after transcatheter aortic valve implantation: Results of the Brazilian registry.
    Catheter Cardiovasc Interv. 2014 Dec 15. doi: 10.1002/ccd.25778.
    PubMed     Text format     Abstract available


  334. STAHLI BE, Gebhard C, Saleh L, Falk V, et al
    N-terminal pro-B-type natriuretic peptide ratio predicts mortality after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2014 Dec 15. doi: 10.1002/ccd.25788.
    PubMed     Text format     Abstract available


  335. LARDIZABAL JA, Macon CJ, O'Neill BP, Desai H, et al
    Long-term outcomes associated with the transaortic approach to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2014 Dec 15. doi: 10.1002/ccd.25785.
    PubMed     Text format     Abstract available


  336. POZZI M, Grinberg D, Obadia JF, Saroul C, et al
    Transcatheter aortic valve implantation using the left transcarotid approach in patients with previous ipsilateral carotid endarterectomy.
    Catheter Cardiovasc Interv. 2014 Dec 15. doi: 10.1002/ccd.25779.
    PubMed     Text format     Abstract available


  337. VAN DER BOON RM, Houthuizen P, Urena M, Poels TT, et al
    Trends in the occurrence of new conduction abnormalities after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2014 Dec 13. doi: 10.1002/ccd.25765.
    PubMed     Text format     Abstract available


  338. HALLBERGSON A, Rome JJ
    Percutaneous left main coronary artery stent for acute myocardial ischemia after repaired ALCAPA.
    Catheter Cardiovasc Interv. 2014 Dec 13. doi: 10.1002/ccd.25771.
    PubMed     Text format     Abstract available


    November 2014
  339. MARTINEZ BERMUDEZ CA, Van Leer-Greenberg B, Heldman AW
    Multi-modality image guidance with Dyna-CT for transcatheter treatment of paravalvular leak of a stentless valve.
    Catheter Cardiovasc Interv. 2014 Nov 22. doi: 10.1002/ccd.25756.
    PubMed     Text format     Abstract available


  340. KWOK CS, Anderson SG, McAllister KS, Sperrin M, et al
    Impact of age on the prognostic value of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention; insights from the British Cardiovascular Intervention Society.
    Catheter Cardiovasc Interv. 2014 Nov 19. doi: 10.1002/ccd.25732.
    PubMed     Text format     Abstract available


  341. ARRI SS, Poliacikova P, Hildick-Smith D
    Percutaneous paravalvular leak closure for symptomatic aortic regurgitation after CoreValve transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2014 Nov 10. doi: 10.1002/ccd.25730.
    PubMed     Text format     Abstract available


  342. GARG A, Parashar A, Agarwal S, Aksoy O, et al
    Comparison of acute elastic recoil between the SAPIEN-XT and SAPIEN valves in transfemoral-transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2014 Nov 4. doi: 10.1002/ccd.25717.
    PubMed     Text format     Abstract available


    October 2014
  343. BARBASH IM, Minha S, Ben-Dor I, Dvir D, et al
    Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2014 Oct 17. doi: 10.1002/ccd.25708.
    PubMed     Text format     Abstract available


  344. SEIFFERT M, Conradi L, Terstesse AC, Koschyk D, et al
    Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2014 Oct 8. doi: 10.1002/ccd.25691.
    PubMed     Text format     Abstract available


    September 2014
  345. HOFFMAN SJ, Yee AH, Slusser JP, Rihal CS, et al
    Neuroimaging patterns of ischemic stroke after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2014 Sep 25. doi: 10.1002/ccd.25678.
    PubMed     Text format     Abstract available


  346. WATANABE Y, Lefevre T, Arai T, Hayashida K, et al
    Can we predict post-procedural paravalvular leak after Edwards Sapien transcatheter aortic valve implantation?
    Catheter Cardiovasc Interv. 2014 Sep 9. doi: 10.1002/ccd.25665.
    PubMed     Text format     Abstract available


  347. SANBORN TA, Tomey MI, Mehran R, Genereux P, et al
    Femoral vascular closure device use, bivalirudin anticoagulation and bleeding after primary angioplasty for STEMI: Results from the HORIZONS-AMI trial.
    Catheter Cardiovasc Interv. 2014 Sep 1. doi: 10.1002/ccd.25663.
    PubMed     Text format     Abstract available


    August 2014
  348. FREIXA X, Chan J, Bonan R, Ibrahim R, et al
    Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2014 Aug 12. doi: 10.1002/ccd.25632.
    PubMed     Text format     Abstract available


    July 2014
  349. GUERCHICOFF A, Stone GW, Mehran R, Xu K, et al
    Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute st-segment elevation myocardial infarction: Results of the HORIZONS-AMI trial.
    Catheter Cardiovasc Interv. 2014 Jul 30. doi: 10.1002/ccd.25620.
    PubMed     Text format     Abstract available


  350. DE BACKER O, Lonn L, Sondergaard L
    Combined surgical and catheter-based treatment of extensive thoracic aortic aneurysm and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2014 Jul 2. doi: 10.1002/ccd.25592.
    PubMed     Text format     Abstract available


    June 2014
  351. SCHNABEL RB, Seiffert M, Wilde S, Schirmer J, et al
    Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort.
    Catheter Cardiovasc Interv. 2014 Jun 27. doi: 10.1002/ccd.25588.
    PubMed     Text format     Abstract available


    March 2014
  352. ABRAMOWITZ Y, Banai S, Katz G, Steinvil A, et al
    Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease.
    Catheter Cardiovasc Interv. 2014;83:649-54.
    PubMed     Text format     Abstract available


    January 2014
  353. SPIRO J, Venugopal V, Raja Y, Ludman PF, et al
    Feasibility and efficacy of the 2.5L and 3.8L Impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2014 Jan 9. doi: 10.1002/ccd.25355.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: